Table 2.

Blood cell indices for Townes AS BM–transplanted Cyb5R3wt and Cyb5R3fl chimeras before tamoxifen treatment (day −1) and at end of 3-week study

PretamoxifenEnd of studyStatistical significance, P
AS/R3wt, n = 10AS/R3fl, n = 14AS/R3WT, n = 10AS/R3KD, n = 14AS/R3WT vs AS/R3wtAS/R3KD vs AS/R3fl
Hct, % 36.74 ± 0.62 34.37 ± 0.69 35.19 ± 0.56 33.58 ± 0.58 .079 .389 
Hgb, g/dL 13.08 ± 0.19 12.24 ± 0.21 12.74 ± 0.27 11.88 ± 0.16 .323 .188 
MCV, fL 32.67 ± 0.5 32.3 ± 0.16 33.07 ± 0.68 33.16 ± 0.26 .64 .008 
RDW, % 31.56 ± 1.23 29.99 ± 0.23 33.09 ± 1.84 31.51 ± 0.51 .498 .060 
MCH, pg 11.66 ± 0.69 11.51 ± 0.07 11.96 ± 0.32 11.76 ± 0.13 .492 .109 
RBC, 1012/L 11.27 ± 0.27 10.63 ± 0.22 10.66 ± 0.15 10.12 ± 0.16 .061 .067 
WBC, ×109/L 18.87 ± 0.91 12.24 ± 1.20 13.67 ± 0.75 10.09 ± 0.91 .0003 .165 
PLT, ×109/L 1173 ± 11.1 983 ± 33.3 1208 ± 11.7 929 ± 29.9 .829 .232 
MPV, fL 7.3 ± 0.06 7.13 ± 0.04 7.18 ± 0.06 7.19 ± 0.06 .299 .309 
PretamoxifenEnd of studyStatistical significance, P
AS/R3wt, n = 10AS/R3fl, n = 14AS/R3WT, n = 10AS/R3KD, n = 14AS/R3WT vs AS/R3wtAS/R3KD vs AS/R3fl
Hct, % 36.74 ± 0.62 34.37 ± 0.69 35.19 ± 0.56 33.58 ± 0.58 .079 .389 
Hgb, g/dL 13.08 ± 0.19 12.24 ± 0.21 12.74 ± 0.27 11.88 ± 0.16 .323 .188 
MCV, fL 32.67 ± 0.5 32.3 ± 0.16 33.07 ± 0.68 33.16 ± 0.26 .64 .008 
RDW, % 31.56 ± 1.23 29.99 ± 0.23 33.09 ± 1.84 31.51 ± 0.51 .498 .060 
MCH, pg 11.66 ± 0.69 11.51 ± 0.07 11.96 ± 0.32 11.76 ± 0.13 .492 .109 
RBC, 1012/L 11.27 ± 0.27 10.63 ± 0.22 10.66 ± 0.15 10.12 ± 0.16 .061 .067 
WBC, ×109/L 18.87 ± 0.91 12.24 ± 1.20 13.67 ± 0.75 10.09 ± 0.91 .0003 .165 
PLT, ×109/L 1173 ± 11.1 983 ± 33.3 1208 ± 11.7 929 ± 29.9 .829 .232 
MPV, fL 7.3 ± 0.06 7.13 ± 0.04 7.18 ± 0.06 7.19 ± 0.06 .299 .309 

AS/R3wt and AS/R3fl are AS/R3WT and AS/R3KD groups, respectively, before tamoxifen treatment. Values are mean ± SEM using the paired Student t test.

or Create an Account

Close Modal
Close Modal